Search Results | DrugBank Online

Displaying drugs 15176 - 15200 of 15220 in total

VLTS-589

VLTS-589 consists of plasmid encoding the angiomatrix protein Del-1 in conjunction with poloxamer 188 for the treatment of peripheral vascular disease.

Investigational

N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine

Experimental

1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE

Experimental

5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one

Experimental

(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one

Experimental

99mTc-glucarate

99mTc-glucarate(GLA) is an agent for non-invasive detection of breast tumours.

Investigational

1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE

Experimental

Ghavamiol

Experimental

Buflomedil

Experimental

1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE

Experimental

Cerlapirdine

Cerlapirdine has been investigated for the treatment of Alzheimer Disease.

Investigational

BMS-863233

BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.

Investigational

1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine

Experimental

Moperone

Experimental

Propiopromazine

Experimental

Vet approved

PA-1050040

PA1050040, a second generation HIV-1 maturation inhibitor, is a chemical analog of Bevirimat (BVM). It inhibits virus replication by the same mechanism of action as BVM.

Investigational